Insights

Advanced Therapy Medicinal Products ReciBioPharm specializes in developing and manufacturing ATMPs, providing an opportunity for sales representatives to target companies in need of these advanced biological modalities.

Collaboration with LenioBio By partnering with LenioBio for scaling up protein manufacturing, ReciBioPharm positions itself as a strategic partner for companies looking to expedite vaccine production, creating a sales opportunity for vaccine developers.

Management Expertise With a management team and technical experts experienced in process development and manufacturing, ReciBioPharm can leverage their expertise to attract companies seeking knowledgeable partners for product development, presenting a sales opening.

Revenue Range With a revenue between $10M - $50M, ReciBioPharm falls into a lucrative segment that appeals to mid-sized pharmaceutical companies looking for CDMOs with proven capabilities, making it a potential target for sales engagements.

Biosimilar Market Expansion Considering the trend towards advanced biological therapies and vaccine production, ReciBioPharm's focus on these areas aligns with the growing market demands, presenting a prime opportunity for sales representatives to capitalize on the expanding biosimilar market.

Similar companies to ReciBioPharm

ReciBioPharm Tech Stack

Media & News

LenioBio GmbH partnered with ReciBiopharm on Oct 2nd '24.
October 2nd, 2024 - LenioBio, the leader in rapid cell-free protein expression technologies, is pleased to announce a collaboration with ReciBioPharm, a global contract development and manufacturing organization (CDMO), to scale up protein manufacturing capabilities and expedite vaccine production.
Oct 03, 2024 | www.recipharm.com

ReciBioPharm's Email Address Formats

ReciBioPharm uses at least 2 format(s):

ReciBioPharm Email Formats	Example	Percentage
First.Last@arrantabio.com	John.Doe@arrantabio.com	99%
First.MiddleLast@arrantabio.com	John.MichaelDoe@arrantabio.com	1%

Frequently Asked Questions

Where is ReciBioPharm's headquarters located?

ReciBioPharm's main headquarters is located at Watertown, MA 02472 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is ReciBioPharm's official website and social media links?

ReciBioPharm's official website is recibiopharm.com and has social profiles on LinkedIn.

How much revenue does ReciBioPharm generate?

As of December 2024, ReciBioPharm's annual revenue reached $15M.

What is ReciBioPharm's NAICS code?

ReciBioPharm's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ReciBioPharm have currently?

As of December 2024, ReciBioPharm has approximately 201 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Quality & Regulatory Officer: M. C. M.Head Of Procurement: R. H.Director, Head Of Aav/Lv Process Development, Cmc, Pdna & Mrna, Cell Line, Tech Transfer, Pm: X. L.. Explore ReciBioPharm's employee directory with LeadIQ.

What industry does ReciBioPharm belong to?

ReciBioPharm operates in the Pharmaceutical Manufacturing industry.

What is ReciBioPharm's email format?

ReciBioPharm's email format typically follows the pattern of . Find more ReciBioPharm email formats with LeadIQ.

ReciBioPharm

Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees

ReciBioPharm, a division of Recipharm, is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs). ReciBioPharm’s specialized CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid based mRNA and plasmid DNA production. 
 
Led by a management team and technical experts with a proven track record in both  process development and contract manufacturing, ReciBioPharm offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.